2. Search Result
Search Result
Results for "

BIIB-021

" in MedChemExpress (MCE) Product Catalog:
製品番号 製品名 Target 研究分野 構造式
  • HY-10212
    BIIB021
    4 Publications Verification

    CNF2024

    		 HSP Autophagy Cancer
    BIIB021 (CNF2024) is an orally active, fully synthetic inhibitor of HSP90 with a Ki and an EC50 of 1.7 nM and 38 nM, respectively .
    BIIB021
  • HY-10212A
    BIIB021 mesylate

    CNF2024 mesylate

    		 HSP β-catenin c-Myc Autophagy Cancer
    BIIB021 (CNF2024) mesylate is the mesylate of BIIB021 (HY-10212). BIIB021 is an orally active Hsp90 inhibitor. BIIB021 inhibits the proliferation of chronic myeloid leukemia (CML) cells, with IC50 values of K562, K562/G, 32Dp210, and 32Dp210-T315I cells are 513.99, 603.53, 110.08, and 148.07 nM, respectively. BIIB021 degrades BCR-ABL protein and inhibits the β-catenin/c-Myc pathway. BIIB021 can also induce autophagy in CML cells. BIIB021 can be used for the research of CML .
    BIIB021 mesylate
  • HY-10212R
    BIIB021 (Standard)

    CNF2024 (Standard)

    		 Reference Standards HSP Autophagy Cancer
    BIIB021 (Standard) is the analytical standard of BIIB021. This product is intended for research and analytical applications. BIIB021 (CNF2024) is an orally active, fully synthetic inhibitor of HSP90 with a Ki and an EC50 of 1.7 nM and 38 nM, respectively .
    BIIB021 (Standard)
  • HY-169141
    BIIB021-NH-C2-piperidine-CO-Me

    		E3 Ligase Ligand-Linker Conjugates Cancer
    BIIB021-NH-C2-piperidine-CO-Me is a E3 ligase ligand-linker conjugate that can be used in the synthesis of PROTACT (HY-169133) .
    BIIB021-NH-C2-piperidine-CO-Me

オンラインお問い合わせ

入力情報は安全に管理されます. ※ 必須入力項目.

タイトル

  

国或いは地域 *

お名前 *

 

組纖名 *

デパートメント *

     

メールアドレス *

 

製品名 *

製品番号

  

カスタマ需要量 *

電話番号 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
製品番号:
数量:
MCE 日本正規代理店: